Introducing X-MAN – The Model Cancer Patient

Add to your list(s) Download to your calendar using vCal

• Dr Darrin Disley, (1991-96 PhD Biotechnology), Executive Chairman of Horizon Discovery Ltd and Director of New Ventures of Execute Technologies
• Friday 26 November 2010, 17:00-18:00
• Dept Chemical Engineering and Biotechnology, New Museums Site, Pembroke Street, CB2 3RA.

If you have a question about this talk, please contact Elena Gonzalez on eg314.

Need to register in advance on http://www.ceb.cam.ac.uk/pages/alumni-speaker-series.html

This proprietary virally-mediated human gene-editing technology enables any endogenous gene in a human cell-line to be altered quickly, reliably and without introducing unwanted and confounding genotypes and/or phenotypes. X-MAN cell lines accurately model the disease-causing mutations observed in cancer patients and are being used by academic and industry leaders to identify the effect of individual mutations on drug activity, patient responsiveness and resistance, and to successfully predict which patient sub-groups will respond to currently-available and future drug treatments. The findings from the company’s scientific founders and advisors are defining how targeted colorectal cancer drugs are developed and prescribed.

This talk is part of the CEB Alumni Speaker Series series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• CEB Alumni Speaker Series
• CamBridgeSens
• Cambridge talks
• Chemical Engineering and Biotechnology
• Dept Chemical Engineering and Biotechnology, New Museums Site, Pembroke Street, CB2 3RA
• Featured lists
• ME Seminar
• School of Technology
• Trust & Technology Initiative - interesting events

Note that ex-directory lists are not shown.